KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TAK) Return on Sales (2017 - 2025)

Historic Return on Sales for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to 0.14%.

  • Takeda Pharmaceutical's Return on Sales fell 500.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.29%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.02% for FY2025, which is 100.0% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Return on Sales of 0.14% as of Q4 2025, which was down 500.0% from 0.31% recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Return on Sales ranged from a high of 0.35% in Q1 2025 and a low of 0.07% during Q3 2022
  • Over the past 5 years, Takeda Pharmaceutical's median Return on Sales value was 0.19% (recorded in 2023), while the average stood at 0.2%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -2200bps in 2022, then soared by 2700bps in 2025.
  • Takeda Pharmaceutical's Return on Sales (Quarter) stood at 0.1% in 2021, then decreased by -10bps to 0.09% in 2022, then soared by 186bps to 0.25% in 2023, then decreased by -23bps to 0.19% in 2024, then fell by -28bps to 0.14% in 2025.
  • Its Return on Sales stands at 0.14% for Q4 2025, versus 0.31% for Q3 2025 and 0.32% for Q2 2025.